KRAS G12C inhibitor 37

Modify Date: 2024-01-10 18:31:42

KRAS G12C inhibitor 37 Structure
KRAS G12C inhibitor 37 structure
Common Name KRAS G12C inhibitor 37
CAS Number 2241720-04-5 Molecular Weight 660.73
Density N/A Boiling Point N/A
Molecular Formula C35H39F3N8O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of KRAS G12C inhibitor 37


KRAS G12C inhibitor 37 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 37 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2018143315A1, compound 65)[1].

 Names

Name KRAS G12C inhibitor 37

 KRAS G12C inhibitor 37 Biological Activity

Description KRAS G12C inhibitor 37 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 37 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2018143315A1, compound 65)[1].
Related Catalog
References

[1]. Quinazoline compound. Patent WO2018143315A1.

 Chemical & Physical Properties

Molecular Formula C35H39F3N8O2
Molecular Weight 660.73